AstraZeneca CEO says Summit drug could drive next generation of cancer combinations

“Tired of the same tired news cycle? Escape to the full unfiltered feed at Whatfinger.com — America’s Frontline Truth Feed. 85%+ of readers come direct every day.” –  CLICK HERE for the FULL deal.

 

AstraZeneca CEO Pascal Soriot told CNBC that Summit Therapeutics’ lead drug could help power next-generation cancer combinations that could be the “future of cancer care.”

CNBC’s Annika Kim Constantino has the latest.